Spinal Cord Disease in HIV Infection by Keese, Zoe et al.
University of Nebraska Medical Center 
DigitalCommons@UNMC 
Posters: 2021 Summer Undergraduate 
Research Program Summer Undergraduate Research Program 
Summer 8-12-2021 
Spinal Cord Disease in HIV Infection 
Zoe Keese 
University of Nebraska Medical Center 
Amanda Fernandes 
University of Nebraska Medical Center 
Lili Guo 
University of Nebraska Medical Center 
Edward Makarov 
University of Nebraska Medical Center 
Saumi Mathews 
University of Nebraska Medical Center 
See next page for additional authors 
Follow this and additional works at: https://digitalcommons.unmc.edu/surp2021 
Recommended Citation 
Keese, Zoe; Fernandes, Amanda; Guo, Lili; Makarov, Edward; Mathews, Saumi; and Gorantla, Santhi, 
"Spinal Cord Disease in HIV Infection" (2021). Posters: 2021 Summer Undergraduate Research Program. 
54. 
https://digitalcommons.unmc.edu/surp2021/54 
This Poster is brought to you for free and open access by the Summer Undergraduate Research Program at 
DigitalCommons@UNMC. It has been accepted for inclusion in Posters: 2021 Summer Undergraduate Research 
Program by an authorized administrator of DigitalCommons@UNMC. For more information, please contact 
digitalcommons@unmc.edu. 
Author 
Zoe Keese, Amanda Fernandes, Lili Guo, Edward Makarov, Saumi Mathews, and Santhi Gorantla 
This poster is available at DigitalCommons@UNMC: https://digitalcommons.unmc.edu/surp2021/54 
Spinal cord disease in HIV infection.
Zoe Keese1, Amanda Fernandes1, Lili Guo1, Ed Makarov1, Saumi Mathews1, Santhi Gorantla1
Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha
Human microglia in mouse brain Conclusion and Future Directions
• This is the first demonstration of human microglial reconstitution and productive 
HIV infected in a mouse spinal cord. 
• HIV infection resulted in myelin loss in the anterior column white matter.
• Further analysis of glial activation in the grey matter and demyelination in different 
regions of SC and the resulting consequences in behavioral phenotype needs to 
be evaluated.
• Studying SC disease in the human microglial mice during combination 
antiretrovirally (cART) suppressed HIV infection will provide a means to understand 
the disease in people living with HIV (PLWH).
• The new mouse model can be used to study the mechanisms underlying the 
pathology, discover therapeutic targets and for therapeutic testing.
HIV infection is associated with numerous spinal cord diseases, such as vacuolar 
myelopathy, primary HIV-associated acute transverse myelitis, and primary CNS 
lymphoma, amongst others. These diseases had a much higher prevalence in the 
pre-cART era, however, some individuals are still affected despite cART
treatment. Moreover, a previous study has shown that HIV-1 gp120 induces 
synaptic degeneration in the spinal pain neural circuit, which is likely a critical step 
in neuropathogenesis of the spinal cord in HIV. Further study is needed to better 
understand how HIV patients are affected by spinal cord disease, and to develop 
therapeutic strategies. 
To study HIV in its relation to spinal cord disease, we used a recently developed 
humanized mouse model that has human microglial cell reconstitution. This model 










Human microglial mice can be used to study peripheral neuropathy and spinal cord 
myelopathy in HIV infection
Immune deficient NOD/Scid IL2Rg-/- (NOG) mice when transplanted with human 
CD34+ hematopoietic stem cells (HSC) at birth develop complete human immune 
system that can be studied for the life of the mouse.
When the cytokine human Interleukin-34 (IL-34) was introduced transgenically
into NOG mice, human microglia were spontaneously developed in the mouse 









Myelin loss in the HIV infected SC
HIV infection in the brain
HIV infection in the spinal cord
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A. Immunofluorescence staining for Myelin 
associated glycoprotein (MAG, Red) and 
human microglia (HLA-DR, green) from 
control and HIV mice. B. Quantification of 
MAG fluorescence intensity captured by 
multispectral imaging. 
Immunohistology staining for glial fibrillary acidic protein (GFAP, brown) to assess astrogliosis.  
A. Immunohistology staining for HIV-1 infected microglial cells (top HIV RNA, bottom HIV-1p24, 
brown) in different brain regions (Cerebellum, CB; Cortex, CTX; Hippocampus, HC). B. Plasma 
viral RNA levels at 3 and 6 weeks post infection, C. Brain viral RNA levels measured by real-
time PCR in IL34-NOG microglial mice. 
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A. Spinal cord HIV RNA levels measured by droplet digital PCR (DDPCR). B. Immunohistology 
staining for human microglia (HLA-DR, brown). Bottom panels show multi-nucleated giant cells 
that are typical pathological feature I. HIV infection. HIV-1 infected microglial cells (HIV-1p24, 
brown) are also present at significant levels.
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A. Immunohistology staining of brain and different tissues for human microglia and 
macrophages (HLA-DR, brown) in humanized NSG. And IL-34-NOG mice. Human microglia are 
present only in humanized IL34-NOG mice. B. Human cells in mouse brain had typical 
microglial morphology.
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